IgA modulates respiratory dysfunction as a sequela to pulmonary chlamydial infection as neonates

Area of Science:

• Immunology
• Respiratory Medicine
• Infectious Diseases

Background:

• Neonatal Chlamydia lung infections can lead to severe respiratory problems later in life, including asthma.
• Previous research highlighted the role of T-helper 1 (Th1) cytokines (IL-12, IFN-γ) in neonatal Chlamydia protection.
• The contribution of the humoral immune system, particularly B-cells and IgA, remained unclear.

Purpose of the Study:

• To investigate the protective role of B-cells and Immunoglobulin A (IgA) in neonatal mice against Chlamydia muridarum pulmonary infection.
• To determine if B-cells and IgA influence the development of long-term respiratory sequelae following neonatal Chlamydia infection.

Main Methods:

• Neonatal wild-type (WT), IgA-deficient (IgA(-/-)), and B-cell-deficient (μMT) mice were challenged with a sublethal dose of Chlamydia muridarum.
• Bacterial burdens in the lungs were monitored over time post-infection.
• Respiratory function was assessed 5 weeks post-challenge using pulmonary function analyses (e.g., P-V loops, dynamic resistance).

Main Results:

• All WT and IgA(-/-) mice survived the infection with comparable bacterial clearance.
• B-cell-deficient (μMT) mice showed high mortality, indicating a critical role for B-cells in acute survival.
• IgA(-/-) mice exhibited increased respiratory dysfunction, including altered pressure-volume loops and higher dynamic resistance, suggesting a role for IgA in preventing long-term pathology.

Conclusions:

• B-cells are essential for neonatal survival following pulmonary Chlamydia infection.
• While not critical for initial bacterial clearance, IgA plays a significant role in mitigating the development of Chlamydia-induced respiratory dysfunction later in life.
• These findings underscore the importance of mucosal immunity, specifically IgA, in preventing chronic respiratory sequelae from neonatal Chlamydia infections.